The lymphatic system serves an integral role in fluid homeostasis, lipid metabolism and immune control of the human body. Lipid based nano-carriers employing lymphatic voyage offer multitude of advantages like enhanced bioavailability, selective targeting to localized as well as metastatic conditions, controlled delivery and others. Lipid-based nano-carriers have been tested on various experimental various in-vivo, in-vitro, ex-vivo and in-silico models. The in-vivo models provide the best drug transport estimation, but they are both invasive and irreversible.